Lund, Sweden, 16 December 2025. Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), today announced that GOOD-IDES-02, a global pivotal Phase 3 trial in anti-glomerular basement membrane (anti-GBM) ...

Background One in seven households in England live in accommodation not meeting housing quality standards. Low-quality ...

Pricer, the global retail tech leader specializing in transforming the shelf edge into a dynamic communications platform, announced today its participation at the National Retail Federation (NRF) 2026 ...

Among sharks and rays, species within the first four million years of existence are significantly more likely to go extinct than older species, ...